BTIS
AZN icon

BB&T Investment Services’s AstraZeneca AZN Stock Holding History

BB&T Investment Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$964K Buy
14,018
+2,450
+21% +$165K 0.16% 133
2017
Q3 		$782K Buy
11,568
+4,099
+55% +$259K 0.16% 134
2017
Q2 		$512K Buy
7,469
+2,052
+38% +$134K 0.13% 148
2017
Q1 		$343K Buy
5,417
+3,649
+206% +$212K 0.13% 149
2016
Q4 		$96K Buy
+1,768
New +$100K 0.07% 209

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB&T Investment Services's AZN Position: Q4 2017 in Review

BB&T Investment Services increased its AstraZeneca (AZN) stake by 21% in Q4 2017, buying an estimated $165K and bringing the position to 14,018 shares worth $964K. The position accounts for 0.16% of the portfolio, ranked #133.

BB&T Investment Services first reported a position in AZN in Q4 2016 and has held it in 5 quarters since. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

  • BB&T Investment Services held 14,018 shares of AstraZeneca worth $964K as of Q4 2017.
  • BB&T Investment Services bought 2,450 AstraZeneca shares in Q4 2017, an estimated $165K.
  • AstraZeneca made up 0.16% of BB&T Investment Services's portfolio in Q4 2017, its #133 holding.
  • BB&T Investment Services first reported a position in AstraZeneca in Q4 2016 and has held it in 5 quarters since.
  • 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.